Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Randomized, double-blind, placebo-controlled trial of the once-daily glp-1 receptor agonist lixisenatide in asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a sulfonylurea (Getgoal-L-Asia)
Stop using products like retinoids or BHA/AHA 3 to 5 days before your treatment
Lower glutathione puts cells at risk for faster aging and more damage from daily life
Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
US$ 26.21
US$ 21.39
US$ 20.67
US$ 26.38
US$ 20.11
US$ 21.48
US$ 20.37
